| Presented by: | The Cleveland Clinic Foundation Center for Continuing Education |
| Lecturer | William D. Carey, MD and Robert Dreicer, MD, MS, FACP |
| Approximate duration: | 1 hr. |
| Summary points: | In this audiovisual CME activity, an expert in oncology analyses the implications of new screening date for prostate cancer and contrasts the risks and benefits of androgen deprivation therapy for non-metastatic prostate cancer. |
| Accreditation: | The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit.
Expiration Date: October 9, 2010. |
| Other: | |
E-Mail this webcast/CME to a colleague
Prostate Cancer: Recent Developments Relevant for Internal Medicine Physicians
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
